Met Life Investment Management, LLC Athira Pharma, Inc. Transaction History

Met Life Investment Management, LLC

$17.1 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$2.74 - $13.43 $58,170 - $285,118	-21,230 Closed	0 $0
Q1 2022 May 10, 2024	BUY	$8.96 - $13.51 $190,220 - $286,817	21,230 New	21,230 $286,000
Q1 2022 Jun 20, 2023	BUY	$8.96 - $13.51 $190,220 - $286,817	21,230 New	21,230 $286,000
Q1 2022 Mar 22, 2023	BUY	$8.96 - $13.51 $67,441 - $101,689	7,527 Added 54.93%	21,230 $286,000
Q1 2022 May 12, 2022	BUY	$8.96 - $13.51 $67,441 - $101,689	7,527 Added 54.93%	21,230 $287,000
Q4 2021 May 17, 2024	BUY	$9.17 - $16.39 $57,981 - $103,633	6,323 Added 85.68%	13,703 $178,000
Q4 2021 Jun 21, 2023	BUY	$9.17 - $16.39 $125,656 - $224,592	13,703 New	13,703 $178,000
Q4 2021 Mar 22, 2023	BUY	$9.17 - $16.39 $57,981 - $103,633	6,323 Added 85.68%	13,703 $178,000
Q4 2021 Feb 15, 2022	BUY	$9.17 - $16.39 $57,981 - $103,633	6,323 Added 85.68%	13,703 $179,000
Q3 2021 May 17, 2024	SELL	$9.15 - $11.09 $72,943 - $88,409	-7,972 Reduced 51.93%	7,380 $69,000
Q3 2021 Jun 21, 2023	BUY	$9.15 - $11.09 $67,527 - $81,844	7,380 New	7,380 $69,000
Q3 2021 Mar 22, 2023	SELL	$9.15 - $11.09 $72,943 - $88,409	-7,972 Reduced 51.93%	7,380 $69,000
Q3 2021 Nov 15, 2021	SELL	$9.15 - $11.09 $72,943 - $88,409	-7,972 Reduced 51.93%	7,380 $69,000
Q2 2021 May 17, 2024	BUY	$10.24 - $20.87 $157,204 - $320,396	15,352 New	15,352 $157,000
Q2 2021 Jun 21, 2023	BUY	$10.24 - $20.87 $157,204 - $320,396	15,352 New	15,352 $157,000
Q2 2021 Mar 22, 2023	BUY	$10.24 - $20.87 $92,518 - $188,560	9,035 Added 143.03%	15,352 $157,000
Q2 2021 Aug 16, 2021	BUY	$10.24 - $20.87 $157,204 - $320,396	15,352 New	15,352 $157,000
Q1 2021 May 14, 2021	SELL	$16.9 - $29.77 $106,757 - $188,057	-6,317 Closed	0 $0
Q4 2020 May 24, 2024	BUY	$16.48 - $34.3 $104,104 - $216,673	6,317 New	6,317 $216,000
Q4 2020 Jun 22, 2023	BUY	$16.48 - $34.3 $104,104 - $216,673	6,317 New	6,317 $216,000
Q4 2020 Mar 22, 2023	BUY	$16.48 - $34.3 $104,104 - $216,673	6,317 New	6,317 $216,000
Q4 2020 Feb 16, 2021	BUY	$16.48 - $34.3 $104,104 - $216,673	6,317 New	6,317 $216,000

Others Institutions Holding ATHA

# of Institutions

Shares Held

16.9M

Call Options Held

112K

Put Options Held

68K

Perceptive Advisors LLC New York, NY

5.4M
Shares

$3.03 Million
0.06% of portfolio
Vanguard Group Inc Valley Forge, PA

1.61M
Shares

$903,315
0.0% of portfolio
Propel Bio Management, LLC Los Angeles, CA

1.49M
Shares

$835,963
0.39% of portfolio
Simplify Asset Management Inc. New York, NY

1.49M
Shares

$835,963
0.04% of portfolio
Black Rock Inc. New York, NY

676K
Shares

$378,696
0.0% of portfolio

View Full List

About Athira Pharma, Inc.

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $21.2M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

More about ATHA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account